PREVENTION OF OXALIPLATIN NEUROPATHY BY DULOXETINE-MEDIATED OCT2 INHIBITION. M. Nepal,H. Taheri,Y. Li,A. Gibson,M. Uddin,A. Sparreboom,S. HuCLINICAL PHARMACOLOGY & THERAPEUTICS(2022)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要